Amid wellness craze, FDA weighs lifting peptide restrictions

The Food and Drug Administration is taking the first step toward potentially allowing compounding pharmacies to produce seven peptides that are currently restricted because of the agency’s previous warning over safety concerns....

Redirecting to full article...